TIA HOBBS: Open Payments
NPI 1871210989 · SEBRING, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,847 in 118 payments from 16 companies in 2025. Trend: 2023 $944 · 2024 $1,594 · 2025 $2,847
Food & beverage: $2,847
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 28 | $831 |
| Takeda Pharmaceuticals U.S.A., Inc. | 14 | $295 |
| Regeneron Healthcare Solutions, Inc. | 10 | $271 |
| Grifols USA, LLC | 9 | $195 |
| Verona Pharma, Inc. | 9 | $182 |
| Insmed, Inc. | 7 | $164 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 8 | $163 |
| Merck Sharp & Dohme LLC | 5 | $162 |
| GENZYME CORPORATION | 6 | $161 |
| GlaxoSmithKline, LLC. | 9 | $153 |
Products named: DUPIXENT, GLASSIA, FASENRA, AIRSUPRA, BREZTRI, Prolastin-C Liquid, Ohtuvayre, Arikayce.
Industry payments across FL — which companies pay providers there.
